L T Vlasveld1, E M Rankin. Show Affiliations » 1. Department of Medical Oncology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Huis, Amsterdam.
Abstract
Entities: Disease Gene
Mesh： See more » Antineoplastic Agents/therapeutic useClinical Trials as TopicDrug Administration ScheduleHumansInterleukin-2/adverse effectsInterleukin-2/immunologyInterleukin-2/therapeutic useRecombinant Proteins/therapeutic use
Substances： See more » Antineoplastic AgentsInterleukin-2Recombinant Proteins
Year: 1994 PMID： 8020007 DOI： 10.1016/0305-7372(94)90004-3
Source DB: PubMed Journal: Cancer Treat Rev ISSN： 0305-7372 Impact factor: 12.111